We are live on ! Find out more
WP

WMS Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 11.82%
This Fund
S&P 500
This Quarter Est. Return
-15.74%
1 Year Est. Return
+11.82%
3 Year Est. Return
+10.77%
5 Year Est. Return
+74.56%
10 Year Est. Return
+198.1%
AUM
$360M
AUM Growth
-$87.2M
Cap. Flow
-$11.3M
Cap. Flow %
-3.14%
Top 10 Hldgs %
53.82%
Holding
234
New
16
Increased
50
Reduced
78
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 16.29%
2 Financials 9.64%
3 Healthcare 8.6%
4 Consumer Staples 8.26%
5 Communication Services 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
226
Wells Fargo
WFC
$261B
-8,791
Closed -$473K
WH icon
227
Wyndham Hotels & Resorts
WH
$5.73B
-3,900
Closed -$245K
WSBC icon
228
WesBanco
WSBC
$3.9B
-5,653
Closed -$214K
XBI icon
229
State Street SPDR S&P Biotech ETF
XBI
$10.1B
-6,435
Closed -$612K
CDK
230
DELISTED
CDK Global, Inc.
CDK
-4,995
Closed -$273K
RTN
231
DELISTED
Raytheon Company
RTN
-946
Closed -$208K
UN
232
DELISTED
Unilever NV New York Registry Shares
UN
-4,120
Closed -$237K
ENV
233
DELISTED
ENVESTNET, INC.
ENV
-3,130
Closed -$218K
CIT
234
DELISTED
CIT Group Inc.
CIT
-7,240
Closed -$330K

Similar funds

WMS Partners's Q1 2020 Portfolio in Review

As of Q1 2020, WMS Partners held 234 positions worth $360M, down 19% from $448M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

WMS Partners withdrew a net $11.3M in Q1 2020, closing 43 positions and reducing 78 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $1.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, WMS Partners opened a new position in iShares MSCI Europe Financials ETF worth $564K.

  • WMS Partners's largest Q1 2020 buy was iShares MSCI Europe Financials ETF: 45,000 shares worth $564K.
  • WMS Partners added most to Vanguard Total Stock Market ETF in Q1 2020, an estimated $4.75M increase.
  • WMS Partners's biggest Q1 2020 reduction was McCormick & Company Voting, cutting an estimated $1.94M.
  • WMS Partners fully exited Supernus Pharmaceuticals in Q1 2020, selling an estimated $1.74M.
  • WMS Partners's ten largest holdings make up 54% of its $360M portfolio in Q1 2020.
  • WMS Partners opened 16 new positions and closed 43 in Q1 2020.
  • WMS Partners's portfolio value fell 19% quarter-over-quarter to $360M.

Based on WMS Partners's 13F filing for Q1 2020, filed 13 May 2020.